China's Fudan Hospital implants world's first commercial BCI chip in…

China's Fudan Hospital has implanted NeuraClear Medical Technology's NEO brain-computer interface chip into a patient with spinal cord injury, becoming the first commercial BCI approval and clinical implant ahead of Neuralink's FDA authorisation. The device reads neural signals from the brain surface and converts them into hand movements for rehabilitation. If you're building BCI hardware or neurotech infrastructure outside China, your regulatory and competitive timeline just compressed. China moved from approval to hospital implant in four months and is already covering the device under commercial insurance; the FDA hasn't approved Neuralink yet, and the market window for non-invasive or surface-electrode BCIs is closing fast.